Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-15-123740
Filing Date
2015-04-09
Accepted
2015-04-09 11:39:07
Documents
5
Period of Report
2015-05-21
Effectiveness Date
2015-04-09

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d854434ddef14a.htm DEF 14A 322459
2 GRAPHIC g854434g64i72.jpg GRAPHIC 10616
3 GRAPHIC g854434g83i34.jpg GRAPHIC 182232
4 GRAPHIC g854434g92o80.jpg GRAPHIC 185321
5 GRAPHIC g854434g95j55.jpg GRAPHIC 8747
  Complete submission text file 0001193125-15-123740.txt   857146
Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

EIN.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35420 | Film No.: 15760738
SIC: 2834 Pharmaceutical Preparations